We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.09%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$541B
AUM Growth
+$82.1B
Cap. Flow
+$80.6B
Cap. Flow %
14.9%
Top 10 Hldgs %
15.6%
Holding
10,816
New
1,382
Increased
6,044
Reduced
2,041
Closed
943

Sector Composition

Rank Sector Weight
1 Technology 18.49%
2 Financials 9.06%
3 Consumer Discretionary 7.01%
4 Healthcare 6.25%
5 Industrials 6.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TOP icon
8676
TOP Financial Group
TOP
$1.44B
$5K ﹤0.01%
654
+89
+16% +$768
OBOR icon
8677
Kraneshares MSCI One Belt One Road Index ETF
OBOR
$4.14M
$4.99K ﹤0.01%
+236
New +$5.29K
HSCS icon
8678
Heart Test Laboratories
HSCS
$8.07M
$4.99K ﹤0.01%
1,305
+624
+92% +$2.14K
GUSA icon
8679
Goldman Sachs MarketBeta US 1000 Equity ETF
GUSA
$2.43B
$4.98K ﹤0.01%
98
-10
-9% -$512
VRPX
8680
DELISTED
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
$4.98K ﹤0.01%
524
-293
-36% -$3.89K
JULT icon
8681
AllianzIM U.S. Equity Buffer10 Jul ETF
JULT
$57.4M
$4.97K ﹤0.01%
126
+40
+47% +$1.57K
COAL icon
8682
Range Global Coal Index ETF
COAL
$52.6M
$4.96K ﹤0.01%
+239
New +$5.51K
ERNA icon
8683
Eterna Therapeutics
ERNA
$5.28M
$4.96K ﹤0.01%
45
-178
-80% -$48.3K
ML.WS
8684
DELISTED
MoneyLion Inc. Warrants, each whole warrant exercisable 1/30th of a share of Class A common stock at an exercise price of $345.00 per whole share
ML.WS
$4.95K ﹤0.01%
27,056
+19,033
+237% +$1.99K
TDSB icon
8685
Exchange Listed Funds Trust ETC Cabana Target Beta ETF
TDSB
$49.6M
$4.94K ﹤0.01%
+228
New +$5.13K
FLR icon
8686
PUT
Fluor
FLR
$7.3B
$4.93K ﹤0.01%
+100
New +$5.27K
TGLR icon
8687
Wedbush Laffer Tengler New Era Value ETF
TGLR
$38.9M
$4.93K ﹤0.01%
166
+161
+3,220% +$4.87K
ASPS icon
8688
Altisource Portfolio Solutions
ASPS
$63.3M
$4.91K ﹤0.01%
933
-1,448
-61% -$10.8K
WWR icon
8689
Westwater Resources
WWR
$79.1M
$4.9K ﹤0.01%
+6,921
New +$3.98K
JADE
8690
JPMorgan Active Developing Markets Equity ETF
JADE
$31.1M
$4.88K ﹤0.01%
105
+66
+169% +$3.22K
FFDI
8691
Fidelity Fundamental Developed International ETF
FFDI
$19.9M
$4.88K ﹤0.01%
+200
New +$5.05K
ACXP icon
8692
Acurx Pharmaceuticals
ACXP
$6.58M
$4.85K ﹤0.01%
+298
New +$8.97K
ENSC icon
8693
Ensysce Biosciences
ENSC
$6.61M
$4.84K ﹤0.01%
595
-6,917
-92% -$47.7K
ISHP icon
8694
First Trust Exchange-Traded Fund VI First Trust S-Network E-Commerce ETF
ISHP
$5.56M
$4.84K ﹤0.01%
137
+33
+32% +$1.19K
LNSR icon
8695
LENSAR
LNSR
$73.9M
$4.84K ﹤0.01%
541
-13
-2% -$86
FDIF icon
8696
Fidelity Disruptors ETF
FDIF
$107M
$4.83K ﹤0.01%
+153
New +$4.83K
DUKX
8697
Ocean Park International ETF
DUKX
$3.74M
$4.8K ﹤0.01%
200
+100
+100% +$2.53K
ACSI icon
8698
American Customer Satisfaction ETF
ACSI
$118M
$4.8K ﹤0.01%
+79
New +$4.77K
MLSS icon
8699
Milestone Scientific
MLSS
$42M
$4.79K ﹤0.01%
4,986
+4,642
+1,349% +$3.83K
FYEE icon
8700
Fidelity Yield Enhanced Equity ETF
FYEE
$226M
$4.78K ﹤0.01%
+179
New +$4.84K

Similar funds

UBS Group's Q4 2024 Portfolio in Review

As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.

  • UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
  • UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
  • UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
  • UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
  • UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
  • UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
  • UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.

Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.